CAS SciFinderⁿ

Confidence

84% of researchers* agree CAS SciFinderⁿ allows them to work more confidently than other research solutions.

Speed

77% of researchers* agree CAS SciFinderⁿ allows them to work more quickly than other research solutions.

Innovation

84% of researchers* agree CAS SciFinderⁿ allows them to be more innovative than other research solutions.

*CAS SciFinderⁿ Productivity Survey 2020.

Accelerate Literature Review

Cut literature review time in half* with the most advanced relevance engine in the industry that improves the meaningfulness of each search and produces more precise results.

*CAS SciFinderⁿ Productivity Survey 2020

Assess the IP Landscape

Get a better view of the IP landscape to enable you to bring your innovation to market successfully based on a clear understanding of opportunities, risks, and other activity in the space.

Devise Synthesis Plans

Devise synthesis plans in half the time* with one of the largest databases of single- and multi-step reactions enhanced with reaction conditions, yields, catalysts, and experimental procedures.

*CAS SciFinderⁿ Productivity Survey 2020

Conduct comprehensive biologics research with access to more than 54 million references from the world’s published scientific patent and journal literature to uncover connections you can’t see anywhere else.

Visualize Search Results

Make better decisions faster with user-friendly visualization tools that pinpoint trends, patterns, and outliers, helping you turn information into insights.

Find Available Chemicals

Source materials during research with verified catalogs from hundreds of suppliers covering millions of unique commercially available products with available quantities, prices, and supplier contact information.

CAS SciFinderⁿ keeps me out of the library and in the lab.

Source: TechValidate. TVID: 9E4-509-143

Robert Bonsall

Graduate Student

University of Michigan

Resources

Lipid Nanoparticles Whitepaper cover image

Whitepapers

Lipid Nanoparticles: Past, Present, and Future Opportunities

Lipid nanoparticles play critical roles in mRNA vaccines for treating COVID-19, but their use is not new. Read about past, present, and future opportunities.

Press Releases

CAS Launches Significant Enhancement to Predictive Retrosynthetic Capabilities in SciFinderⁿ

CAS announces significant enhancements to the predictive retrosynthetic capabilities in SciFinderⁿ. The enhanced platform uses state-of-the-art AI technology to improve both accuracy and innovativeness of predicted results.

CAS Biomedical Knowledge Graph whitepaper cover thumbnail

Whitepapers

Knowledge Graphs Accelerate COVID-19 Therapies

This whitepaper details the CAS Biomedical Knowledge Graph and shows how it was used in drug discovery for COVID-19.

See More Resources

Confidence

Speed

Innovation